title: Actovegin reduces the ROS level in blood samples of heart failure patients and diminishes necrosis of SK-N-SH human neuroblastoma cells.
authors.affiliation: Sechenov First Moscow State Medical University, Moscow, Russia.
authors.forename: E I
authors.initials: EI
authors.lastname: Astashkin
authors.forename: M G
authors.initials: MG
authors.lastname: Glezer
authors.forename: M G
authors.initials: MG
authors.lastname: Vinokurov
authors.forename: N D
authors.initials: ND
authors.lastname: Egorova
authors.forename: N S
authors.initials: NS
authors.lastname: Orekhova
authors.forename: A N
authors.initials: AN
authors.lastname: Novikova
authors.forename: S V
authors.initials: SV
authors.lastname: Grachev
authors.forename: M M
authors.initials: MM
authors.lastname: Yurinskaya
authors.forename: K E
authors.initials: KE
authors.lastname: Sobolev
mesh_terms: D000975:Antioxidants / Q000494:pharmacology*; D045744:Cell Line, Tumor; D005260:Female; D006333:Heart Failure / Q000097:blood* / Q000473:pathology; D006418:Heme / Q000031:analogs & derivatives* / Q000494:pharmacology; D006801:Humans; D008297:Male; D009336:Necrosis; D009447:Neuroblastoma / Q000378:metabolism* / Q000473:pathology; D017382:Reactive Oxygen Species / Q000097:blood*
chemical_list: D000975:Antioxidants; D017382:Reactive Oxygen Species; D006418:Heme; C015646:Actovegin